UC Berkeley, UCSF, and UCLA cited AllCells CD34+ from mobilized donors for sickle cell gene therapy (CRISPR-Cas9), in a paper published in " Science" (Translational Medicine)!
Read more about this exciting paper here:
AllCells is committed to providing researchers with products and services in order to advance their scientific experiments. As part of this mission, AllCells completed a collaboration with Amgen, the world's largest biotechnology firm. This collaboration resulted in a successful research project which led to a poster presentation at the Read More
In the following publication, “HUVECs (ALLCELLS, Shanghai, China, 2 × 104 cells/well) suspended in 100 μl of medium supplemented with 0.5% FBS were added to each well and cultured in triplicate with 150 μl of CM from either Src or GPR120 KD cells at 37 °C." Read More